Avadel Pharmaceuticals plc (NASDAQ: AVDL) Stock Information | RedChip

Avadel Pharmaceuticals plc (NASDAQ: AVDL)


$15.4700
+2.5600 ( +19.83% ) 5.1M

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. It identifies, develops, and commercializes branded pharmaceutical products including controlled-release therapeutic products based on its proprietary drug delivery technologies in the United States. The company is engaged in development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy.

Market Data


Open


$15.4700

Previous close


$12.9100

Volume


5.1M

Market cap


$1.49B

Day range


$14.8500 - $16.7350

52 week range


$9.9800 - $19.0900

SEC Filings


Form Type Description Pages Date
8-k 8K-related 14 Oct 31, 2024
8-k 8K-related 19 Oct 17, 2024
4 Insider transactions 1 Sep 16, 2024
4 Insider transactions 1 Sep 13, 2024
8-k 8K-related 13 Sep 12, 2024
8-k 8K-related 13 Aug 28, 2024
10-q Quarterly Reports 66 Aug 08, 2024
8-k 8K-related 14 Aug 08, 2024
8-k 8K-related 13 Aug 01, 2024
4 Insider transactions 1 Aug 01, 2024

Latest News